Conjuchem

ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DAC^TM) and Preformed Conjugate-Drug Affinity Complex (PC-DAC^TM). When applied to a given peptide, DAC^TM and PC-DAC^TM can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.